Differences in cancer survival by type of insurance

December 4, 2017

(HealthDay)—From 1997 to 2014, improvements in cancer survival were mainly limited to patients with private or Medicare insurance, according to a study published online Nov. 30 in JAMA Oncology.

Libby Ellis, Ph.D., from the Cancer Prevention Institute of California in Fremont, and colleagues examined trends in by health insurance status from January 1997 to December 2014. Data were included for 1,149,891 patients diagnosed with breast, prostate, colorectal, or , or melanoma.

The researchers found that survival improvements were almost entirely limited to patients with private or Medicare insurance; survival was largely unchanged or declined for patients with other public or no insurance. Cancer-specific mortality was higher in uninsured patients relative to privately insured patients, for all cancers except prostate; the largest disparities were seen from 2009 to 2014 for breast (hazard ratio [HR], 1.72), lung (HR, 1.18 for men and 1.32 for women), and colorectal cancer (HR, 1.30 for women). For all cancers except lung, mortality was higher for patients with other public insurance; the largest disparities were seen from 2009 to 2014 for breast (HR, 1.25), prostate (HR, 1.17), and colorectal cancer (HR, 1.16 for men and 1.11 for women).

"Survival disparities for men with prostate cancer and women with lung or increased significantly over time, reflecting a lack of improvement in survival for patients with other public or no insurance," the authors write.

Explore further: Insurance linked to black-white survival disparities in colorectal cancer

More information: Abstract/Full Text
Editorial (subscription or payment may be required)

Related Stories

Insurance linked to black-white survival disparities in colorectal cancer

November 14, 2017
Health insurance coverage differences account for nearly one-half of the black-white survival disparity in colorectal cancer patients, according to a new study. The study, published in Gastroenterology, reinforces the importance ...

Heart failure is as 'malignant' as some common cancers

May 4, 2017
A new analysis finds that, despite advances in care, men and women with a diagnosis of heart failure continue to have worse survival rates than patients with certain common cancers.

Insurance plays significant role in breast cancer disparities

October 16, 2017
Differences in insurance account for a substantial proportion of the excess risk of death from breast cancer faced by black women, according to a new study. The study, appearing in Journal of Clinical Oncology, concludes ...

Does health insurance status affect childhood cancer survival?

September 11, 2017
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar ...

More cancers diagnosed at early stage following increase in health insurance coverage

May 18, 2017
An analysis of nearly 273,000 patients showed that between 2013 and 2014 there was a 1 percent increase in the percentage of breast, lung, and colorectal cancers diagnosed at the earliest, most treatable stage. Considering ...

Number of newly diagnosed cancer patients without insurance drops in first year of ACA

October 19, 2017
The number of newly diagnosed cancer patients who were uninsured fell by one-third in the first year of the Affordable Care Act's implementation, according to research from Indiana University.

Recommended for you

Drug suppresses spread of breast cancer caused by stem-like cells

December 12, 2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, ...

MRI scans predict patients' ability to fight the spread of cancer

December 12, 2017
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.

Insights on how SHARPIN promotes cancer progression

December 11, 2017
Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

Glioblastoma survival mechanism reveals new therapeutic target

December 11, 2017
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

A new weapon against bone metastasis? Team develops antibody to fight cancer

December 11, 2017
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. "Chemo saves lives and improves survival, but it could work much better ...

Liver cancer: Lipid synthesis promotes tumor formation

December 11, 2017
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.